✦ LIBER ✦

Chemo-immunotherapy in patients with metastatic melanoma using sequential treatment with decarbazine and recombinant human interleukin-2: evaluation of hematologic and immunologic parameters and correlation with clinical response

✍ Scribed by Rut Isacson; Eli Kedar; Vivian Barak; Zulma Gazit; Oded Yurim; Inna Kalichman; Hannah Ben-Bassat; Shoshana Biran; Michael Schlesinger; Christopher R. Franks; Gerda J. Roest; Peter A. Palmer; Eitan Shiloni

Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 576 KB
Volume: 33
Category: Article
ISSN: 0165-2478
DOI: 10.1016/0165-2478(92)90036-n

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of correlation between peripheral b

Lack of correlation between peripheral blood lymphokine-activated killer (lak) cell function and clinical response in patients with advanced malignant melanoma receiving recombinant interleukin 2

✍ A. K. Ghosh; H. Dazzi; N. Thatcher; M. Moore 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 634 KB

A phase-1/11 study of recombinant interleukin 2 (rll-2) was performed in 31 melanoma patients. The first dose of rlL-2 was given intrasplenically followed 4 hr later by an i.v. dose and 3 further i.v. doses on alternate days. Three courses of treatment were planned at 3-week intervals. The maximum t